ResearcherUniversity of PennsylvaniaNo recent work listed

Keisuke Watanabe

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0001-9623-1492; OpenAlex author ID A5056285113. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2018: 1 paper

Papers 1

Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed oncolytic adenoviruses. Co-author DOI 10.1172/jci.insight.99573 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Akseli Hemminki · 1 shared paper, 2018 · strength 0.07
- Paper Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed onco… DOI 10.1172/jci.insight.99573 ↗
John Scholler · 1 shared paper, 2018 · strength 0.07
- Paper Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed onco… DOI 10.1172/jci.insight.99573 ↗
Carl H. June · 1 shared paper, 2018 · strength 0.07
- Paper Pancreatic cancer therapy with combined mesothelin-redirected chimeric antigen receptor T cells and cytokine-armed onco… DOI 10.1172/jci.insight.99573 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.